,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,880,2,1,,29215444,6049,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
1,880,2,1,,29215444,6049,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
2,881,2,2,,29215444,6049,Inactive,317373425.0,247.0,3.5481,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
3,894,2,1,,29215444,6049,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
4,1030,2,1,,29215444,6049,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
5,1195,1,2,,48415936,6049,Active,,,,,DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database,Other,,
6,1379,1,2,,29215444,6049,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
7,1452,1,1,,29215444,6049,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
8,1457,1,1,,29215444,6049,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
9,1460,1,3,,29215444,6049,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
10,1463,1,1,,29215444,6049,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
11,1467,1,3,,29215444,6049,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
12,1468,1,1,,29215444,6049,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
13,1469,1,1,,26754509,6049,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
14,1469,1,1,,29215444,6049,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
15,1471,2,1,,29215444,6049,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
16,1476,2,1,,29215444,6049,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
17,1477,1,1,,29215444,6049,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
18,1478,2,1,,29215444,6049,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
19,1479,1,2,,26754509,6049,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
20,1479,1,2,,29215444,6049,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
21,1487,1,1,,29215444,6049,Inconclusive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
22,1490,2,1,,29215444,6049,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
23,1688,1,1,,29215444,6049,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
24,1766,1,1,,29215444,6049,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
25,1766,1,1,,29215444,6049,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
26,1768,1,1,,29215444,6049,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
27,1768,1,1,,29215444,6049,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
28,1865,1,1,,29215444,6049,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
29,1948,1,1,,29215444,6049,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
30,2101,1,1,,29215444,6049,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
31,2107,1,1,,29215444,6049,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
32,2112,1,1,,29215444,6049,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
33,2314,1,2,,29215444,6049,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
34,2314,1,2,,29215444,6049,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
35,2315,1,2,,29215444,6049,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
36,2315,1,2,,29215444,6049,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
37,2451,1,2,,29215444,6049,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
38,2472,1,2,,29215444,6049,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
39,2528,1,2,,29215444,6049,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
40,2546,1,1,,29215444,6049,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
41,2549,1,1,,29215444,6049,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
42,2551,1,1,,29215444,6049,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
43,2662,2,1,,29215444,6049,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
44,18216,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice blood after 120 hr,Other,10425108.0,
45,18217,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice blood after 1 hr,Other,10425108.0,
46,18218,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice blood after 24 hr,Other,10425108.0,
47,18219,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice blood after 4 hr,Other,10425108.0,
48,18220,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice bone after 120 hr,Other,10425108.0,
49,18221,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice bone after 1 hr,Other,10425108.0,
50,18222,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice bone after 24 hr,Other,10425108.0,
51,18223,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice bone after 4 hr,Other,10425108.0,
52,18224,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice heart after 120 hr,Other,10425108.0,
53,18225,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice heart after 1 hr,Other,10425108.0,
54,18226,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice heart after 24 hr,Other,10425108.0,
55,18227,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice heart after 4 hr,Other,10425108.0,
56,18228,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice kidney after 120 hr,Other,10425108.0,
57,18229,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice kidney after 1 hr,Other,10425108.0,
58,18230,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice kidney after 24 hr,Other,10425108.0,
59,18232,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice liver after 120 hr,Other,10425108.0,
60,18233,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice liver after 1 hr,Other,10425108.0,
61,18234,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice liver after 24 hr,Other,10425108.0,
62,18235,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice liver after 4 hr,Other,10425108.0,
63,18236,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice spleen after 120 hr,Other,10425108.0,
64,18237,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice spleen after 1 hr,Other,10425108.0,
65,18238,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice spleen after 24 hr,Other,10425108.0,
66,18239,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice spleen after 4 hr,Other,10425108.0,
67,18241,6,1,,103224342,6049,Unspecified,,,,,Biodistribution of [225Ac]-labeled compound in normal mice kidney after 4 hr,Other,10425108.0,
68,21034,6,1,,103224342,6049,Unspecified,,,,,Partition coefficient(P) in octanol/water system,Other,10571171.0,
69,51033,8,2,,103224342,6049,Active,,,10.0,EC50,"Concentration required for obtaining 50% of the fluorescence intensity of copper-free calcein 1, in bovine serum albumin",Confirmatory,12729634.0,
70,82757,3,7,,103224342,6049,Unspecified,,,,,Inhibition of human DNA binding to HIV-EP1 (enhancer binding protein) at 0.7 mM concentration,Other,7996537.0,
71,82760,3,7,,103224342,6049,Unspecified,,,,,Inhibition of human DNA binding to HIV-EP1 (enhancer binding protein) at 1.0 mM concentration,Other,7996537.0,
72,82763,3,7,,103224342,6049,Unspecified,,,,,Inhibition of human DNA binding to HIV-EP1 (enhancer binding protein) at 4.0 mM concentration,Other,7996537.0,
73,144304,3,3,,103224342,6049,Inactive,,,,,Antimycobacterial activity was evaluated against Mycobacterium smegmatis; Inactive,Other,11425536.0,
74,144354,6,2,,103224342,6049,Unspecified,,,3500.0,Ki,In vitro inhibition of N8-Acetylspermidine deacetylase from rat liver cytosol,Confirmatory,1619617.0,
75,210778,3,7,,103224342,6049,Unspecified,,,,,"Ability to remove iron from human iron transport protein transferrin, at a concentration of 500 mM, expressed as % iron removal in 30 minutes",Other,6827563.0,
76,210781,3,7,,103224342,6049,Unspecified,,,,,"Ability to remove iron from transferrin, at a concentration of 0.2 mM, expressed as % iron removal in 30 minutes",Other,6827563.0,
77,271694,4,3,,103224342,6049,Unspecified,,,,,Increase in Fe(3+)-mediated ascorbate oxidation at IBE of 1 relative to control,Other,17064069.0,
78,271695,4,3,,103224342,6049,Unspecified,,,,,Increase in Fe(3+)-mediated ascorbate oxidation at IBE of 3 relative to control,Other,17064069.0,
79,271700,4,3,,103224342,6049,Unspecified,,,,,Increase in Fe(2+)-mediated hydroxyl radical production measured as hydroxylation of benzoate at IBE of 3 relative to control,Other,17064069.0,
80,271702,3,3,,103224342,6049,Unspecified,,,,,Increase in Fe(2+)-mediated hydroxyl radical production measured as hydroxylation of benzoate at IBE of 1 relative to control,Other,17064069.0,
81,278726,3,3,,103224342,6049,Unspecified,,,,,Antimicrobial activity against methicillin-resistant Staphylococcus aureus embedded in MRD biofilm model at 30 mg/ml after 15 mins,Other,17074799.0,
82,278727,3,3,,103224342,6049,Unspecified,,,,,Antimicrobial activity against methicillin-resistant Staphylococcus aureus embedded in MRD biofilm model at 30 mg/ml after 15 mins in drug assessed as 24 h regrowth,Other,17074799.0,
83,278732,3,3,,103224342,6049,Unspecified,,,,,Antimicrobial activity against Candida parapsilosis embedded in MRD biofilm at 30 mg/ml after 15 mins,Other,17074799.0,
84,278733,3,4,,103224342,6049,Unspecified,,,,,Antimicrobial activity against Candida parapsilosis embedded in MRD biofilm at 30 mg/ml after 15 mins in drug assessed as 24 hr regrowth,Other,17074799.0,
85,278738,3,3,,103224342,6049,Unspecified,,,,,Antimicrobial activity against methicillin-resistant Staphylococcus aureus in silicone disk biofilm at 30 mg/ml after 60 mins,Other,17074799.0,
86,278739,3,3,,103224342,6049,Unspecified,,,,,Antimicrobial activity against methicillin-resistant Staphylococcus aureus in silicone disk biofilm at 30 mg/ml after 60 mins in drug assessed as 24 h regrowth,Other,17074799.0,
87,278744,3,3,,103224342,6049,Unspecified,,,,,Antimicrobial activity against Candida parapsilosis in silicone disk biofilm at 30 mg/ml after 60 mins,Other,17074799.0,
88,278745,3,3,,103224342,6049,Unspecified,,,,,Antimicrobial activity against Candida parapsilosis in silicone disk biofilm at 30 mg/ml after 60 mins in drug assessed as 24 h regrowth,Other,17074799.0,
89,340739,6,2,,103224342,6049,Unspecified,,,815.0,Ki,Inhibition of Chryseobacterium indologenes metallo-beta-lactamase IND-5 expressed in Escherichia coli BL21(DE3) using nitrocefin reporter substrate,Confirmatory,17470648.0,
90,373169,3,4,,103224342,6049,Inactive,,,,,Induction of cell lysis in Pseudoalteromonas ER72M2 assessed as decrease in culture turbidity in presence of buffer containing Tris-HCL and NaCl,Other,17709471.0,
91,374027,9,5,,103224342,6049,Inactive,75460310.0,,,IC50,Inhibition of Serratia fonticola UTAD54 SFC1 beta lactamase expressed in Escherichia coli BL21(DE3) by SDS-PAGE,Confirmatory,17875998.0,
92,374028,9,5,,103224342,6049,Inactive,75428350.0,,,IC50,Inhibition of Enterobacter cloacae IMI1 beta lactamase expressed in Escherichia coli DH5alpha by SDS-PAGE,Confirmatory,17875998.0,
93,374029,9,6,,103224342,6049,Inactive,205688423.0,6993854.0,,IC50,Inhibition of Klebsiella pneumoniae KPC-1 beta lactamase expressed in Escherichia coli DH5alpha by SDS-PAGE,Confirmatory,17875998.0,
94,374029,9,6,,103224342,6049,Inactive,205688423.0,6993864.0,,IC50,Inhibition of Klebsiella pneumoniae KPC-1 beta lactamase expressed in Escherichia coli DH5alpha by SDS-PAGE,Confirmatory,17875998.0,
95,374029,9,6,,103224342,6049,Inactive,205688423.0,6993875.0,,IC50,Inhibition of Klebsiella pneumoniae KPC-1 beta lactamase expressed in Escherichia coli DH5alpha by SDS-PAGE,Confirmatory,17875998.0,
96,374029,9,6,,103224342,6049,Inactive,205688423.0,9389494.0,,IC50,Inhibition of Klebsiella pneumoniae KPC-1 beta lactamase expressed in Escherichia coli DH5alpha by SDS-PAGE,Confirmatory,17875998.0,
97,374029,9,6,,103224342,6049,Inactive,205688423.0,13914015.0,,IC50,Inhibition of Klebsiella pneumoniae KPC-1 beta lactamase expressed in Escherichia coli DH5alpha by SDS-PAGE,Confirmatory,17875998.0,
98,374029,9,6,,103224342,6049,Inactive,205688423.0,13914300.0,,IC50,Inhibition of Klebsiella pneumoniae KPC-1 beta lactamase expressed in Escherichia coli DH5alpha by SDS-PAGE,Confirmatory,17875998.0,
99,374029,9,6,,103224342,6049,Inactive,205688423.0,13914665.0,,IC50,Inhibition of Klebsiella pneumoniae KPC-1 beta lactamase expressed in Escherichia coli DH5alpha by SDS-PAGE,Confirmatory,17875998.0,
100,374029,9,6,,103224342,6049,Inactive,205688423.0,13923837.0,,IC50,Inhibition of Klebsiella pneumoniae KPC-1 beta lactamase expressed in Escherichia coli DH5alpha by SDS-PAGE,Confirmatory,17875998.0,
101,374029,9,6,,103224342,6049,Inactive,205688423.0,14458347.0,,IC50,Inhibition of Klebsiella pneumoniae KPC-1 beta lactamase expressed in Escherichia coli DH5alpha by SDS-PAGE,Confirmatory,17875998.0,
102,374029,9,6,,103224342,6049,Inactive,205688423.0,15077276.0,,IC50,Inhibition of Klebsiella pneumoniae KPC-1 beta lactamase expressed in Escherichia coli DH5alpha by SDS-PAGE,Confirmatory,17875998.0,
103,374029,9,6,,103224342,6049,Inactive,205688423.0,15564405.0,,IC50,Inhibition of Klebsiella pneumoniae KPC-1 beta lactamase expressed in Escherichia coli DH5alpha by SDS-PAGE,Confirmatory,17875998.0,
104,374029,9,6,,103224342,6049,Inactive,205688423.0,18261808.0,,IC50,Inhibition of Klebsiella pneumoniae KPC-1 beta lactamase expressed in Escherichia coli DH5alpha by SDS-PAGE,Confirmatory,17875998.0,
105,374029,9,6,,103224342,6049,Inactive,205688423.0,18983479.0,,IC50,Inhibition of Klebsiella pneumoniae KPC-1 beta lactamase expressed in Escherichia coli DH5alpha by SDS-PAGE,Confirmatory,17875998.0,
106,374029,9,6,,103224342,6049,Inactive,205688423.0,18983482.0,,IC50,Inhibition of Klebsiella pneumoniae KPC-1 beta lactamase expressed in Escherichia coli DH5alpha by SDS-PAGE,Confirmatory,17875998.0,
107,374029,9,6,,103224342,6049,Inactive,205688423.0,18983485.0,,IC50,Inhibition of Klebsiella pneumoniae KPC-1 beta lactamase expressed in Escherichia coli DH5alpha by SDS-PAGE,Confirmatory,17875998.0,
108,374029,9,6,,103224342,6049,Inactive,205688423.0,18985416.0,,IC50,Inhibition of Klebsiella pneumoniae KPC-1 beta lactamase expressed in Escherichia coli DH5alpha by SDS-PAGE,Confirmatory,17875998.0,
109,374029,9,6,,103224342,6049,Inactive,205688423.0,20493883.0,,IC50,Inhibition of Klebsiella pneumoniae KPC-1 beta lactamase expressed in Escherichia coli DH5alpha by SDS-PAGE,Confirmatory,17875998.0,
110,374029,9,6,,103224342,6049,Inactive,205688423.0,20494301.0,,IC50,Inhibition of Klebsiella pneumoniae KPC-1 beta lactamase expressed in Escherichia coli DH5alpha by SDS-PAGE,Confirmatory,17875998.0,
111,374029,9,6,,103224342,6049,Inactive,205688423.0,30522711.0,,IC50,Inhibition of Klebsiella pneumoniae KPC-1 beta lactamase expressed in Escherichia coli DH5alpha by SDS-PAGE,Confirmatory,17875998.0,
112,377021,3,4,,103224342,6049,Unspecified,,,,,Antispasmodic activity in guinea pig ileum assessed as inhibition of acetylcholine-induced contraction at 1000 uM,Other,16792408.0,
113,378146,6,2,,103224342,6049,Unspecified,,,274.0,IC50,Inhibition of phosphodiesterase-1,Confirmatory,15730241.0,
114,427662,6,2,,103224342,6049,Unspecified,,,185.64,IC50,Antioxidant activity assessed as ferrous ion chelating effect after 10 mins,Confirmatory,19481947.0,
115,485281,1,1,,29215444,6049,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
116,485290,1,1,,29215444,6049,Inactive,20150581.0,,1.2589,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
117,492089,5,2,,103224342,6049,Active,,,0.1,IC50,Antioxidant activity assessed as ferrous ion chelating effect after 10 mins,Confirmatory,20584613.0,
118,492961,1,1,,29215444,6049,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation,Confirmatory,,
119,504327,1,1,,29215444,6049,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
120,504332,1,1,,29215444,6049,Inactive,168985070.0,,0.2818,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
121,504749,1,3,,29215444,6049,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
122,504749,1,3,1.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
123,504749,1,3,2.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
124,504749,1,3,3.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
125,504749,1,3,4.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
126,504749,1,3,5.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
127,504749,1,3,6.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
128,504749,1,3,7.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
129,504749,1,3,8.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
130,504749,1,3,9.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
131,504749,1,3,10.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
132,504749,1,3,11.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
133,504749,1,3,12.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
134,504749,1,3,13.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
135,504749,1,3,14.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
136,504749,1,3,15.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
137,504749,1,3,16.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
138,504749,1,3,17.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
139,504749,1,3,18.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
140,504749,1,3,19.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
141,504749,1,3,20.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
142,504749,1,3,21.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
143,504749,1,3,22.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
144,504749,1,3,23.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
145,504749,1,3,24.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
146,504749,1,3,25.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
147,504749,1,3,26.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
148,504749,1,3,27.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
149,504749,1,3,28.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
150,504749,1,3,29.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
151,504749,1,3,30.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
152,504749,1,3,31.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
153,504749,1,3,32.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
154,504749,1,3,33.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
155,504749,1,3,34.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
156,504749,1,3,35.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
157,504749,1,3,36.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
158,504749,1,3,37.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
159,504749,1,3,38.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
160,504749,1,3,39.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
161,504749,1,3,40.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
162,504749,1,3,41.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
163,504749,1,3,42.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
164,504749,1,3,43.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
165,504749,1,3,44.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
166,504749,1,3,45.0,29215444,6049,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
167,504749,1,3,46.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
168,504749,1,3,47.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
169,504749,1,3,48.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
170,504749,1,3,49.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
171,504749,1,3,50.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
172,504749,1,3,51.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
173,504749,1,3,52.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
174,504749,1,3,53.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
175,504749,1,3,54.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
176,504749,1,3,55.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
177,504749,1,3,56.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
178,504749,1,3,57.0,29215444,6049,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
179,504749,1,3,58.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
180,504749,1,3,59.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
181,504749,1,3,60.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
182,504749,1,3,61.0,29215444,6049,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
183,504832,1,1,,29215444,6049,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
184,504834,1,1,,29215444,6049,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
185,504847,1,1,,29215444,6049,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
186,504865,1,1,,29215444,6049,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
187,530343,8,1,,103224342,6049,Active,75535037.0,,9.3,IC50,Inhibition of Pseudomonas aeruginosa VIM-1 beta-lactamase after 10 mins,Confirmatory,18644957.0,
188,530344,8,1,,103224342,6049,Unspecified,123098121.0,,252.6,IC50,Inhibition of Pseudomonas aeruginosa VIM-13 beta-lactamase after 10 mins,Confirmatory,18644957.0,
189,567091,2,6,,103224342,6049,Unspecified,,,,,Drug absorption in human assessed as human intestinal absorption rate,Other,21112128.0,
190,574481,2,3,,103224342,6049,Active,,,,,Induction of outer membrane permeabilization of Klebsiella pneumoniae ATCC 13883 at 0.5 to 2 mg/mL by DiS-C2 dye based fluorimetric assay,Other,20585129.0,
191,588513,1,1,,26754509,6049,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
192,588514,1,1,,26754509,6049,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
193,588515,1,1,,26754509,6049,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
194,588516,1,1,,26754509,6049,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
195,588526,1,1,,26754509,6049,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
196,588527,1,1,,26754509,6049,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
197,588532,1,1,,26754509,6049,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
198,588533,1,1,,26754509,6049,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
199,588534,1,1,,26754509,6049,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
200,588535,1,1,,26754509,6049,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
201,588536,1,1,,26754509,6049,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
202,588537,1,1,,26754509,6049,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
203,588541,1,1,,26754509,6049,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
204,588543,1,1,,26754509,6049,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
205,588544,1,1,,26754509,6049,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
206,588545,1,1,,26754509,6049,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
207,588546,1,1,,26754509,6049,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
208,588547,1,1,,26754509,6049,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
209,588579,1,1,,29215444,6049,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
210,602332,1,1,,29215444,6049,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
211,624030,1,2,,29215444,6049,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
212,624031,1,2,,29215444,6049,Inactive,,,,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
213,624032,1,2,,29215444,6049,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
214,624044,1,2,,29215444,6049,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
215,624170,1,1,,29215444,6049,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
216,624172,1,1,,29215444,6049,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
217,624173,1,3,,29215444,6049,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
218,624296,1,1,,29215444,6049,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
219,624297,1,1,,29215444,6049,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
220,625279,1,3,,103224342,6049,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia,Other,22194678.0,
221,625280,1,3,,103224342,6049,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis,Other,22194678.0,
222,625281,1,3,,103224342,6049,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis,Other,22194678.0,
223,625282,1,3,,103224342,6049,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis,Other,22194678.0,
224,625283,1,3,,103224342,6049,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests,Other,22194678.0,
225,625284,1,3,,103224342,6049,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure,Other,22194678.0,
226,625285,1,3,,103224342,6049,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis,Other,22194678.0,
227,625286,1,3,,103224342,6049,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis,Other,22194678.0,
228,625287,1,3,,103224342,6049,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly,Other,22194678.0,
229,625288,1,3,,103224342,6049,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice,Other,22194678.0,
230,625289,1,3,,103224342,6049,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease,Other,22194678.0,
231,625290,1,3,,103224342,6049,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty,Other,22194678.0,
232,625291,1,3,,103224342,6049,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal,Other,22194678.0,
233,625292,1,3,,103224342,6049,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score,Other,22194678.0,
234,644237,3,2,,103224342,6049,Unspecified,,,274.0,IC50,Inhibition of Bothrops atrox venom phosphodiesterase-1 assessed as conversion of p-nitrophenyl phosphate to p-nitrophenol using bis(p-nitropheny1) phosphate as substrate preincubated for 30 mins by spectrophotometric analysis,Confirmatory,22264761.0,
235,651631,4,1,,144209934,6049,Inconclusive,269849759.0,7157.0,1.9394,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
236,651632,4,1,,144209934,6049,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
237,651633,4,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
238,651634,4,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
239,651741,1,1,,26754509,6049,Inconclusive,20149576.0,4780.0,24.3365,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
240,651743,1,1,,26754509,6049,Inactive,269849759.0,7157.0,,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
241,651749,1,1,,26754509,6049,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
242,651751,1,1,,26754509,6049,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
243,651777,1,1,,26754509,6049,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
244,651778,1,1,,26754509,6049,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
245,651838,1,1,,26754509,6049,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
246,651838,1,1,1.0,26754509,6049,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
247,651838,1,1,2.0,26754509,6049,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
248,651838,1,1,3.0,26754509,6049,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
249,651838,1,1,4.0,26754509,6049,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
250,651838,1,1,5.0,26754509,6049,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
251,651838,1,1,6.0,26754509,6049,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
252,651838,1,1,7.0,26754509,6049,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
253,651838,1,1,8.0,26754509,6049,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
254,682760,5,5,,103224342,6049,Active,75521105.0,,27.9,IC50,Inhibition of recombinant Pseudomonas aeruginosa MBL IMP-1 using nitrocefin as substrate after 12 hrs by UV-spectrophotometric analysis,Confirmatory,22921080.0,
255,682761,3,6,,103224342,6049,Unspecified,81595821.0,,1060.0,IC50,Inhibition of Bacillus anthracis MBL Bla2 using nitrocefin as substrate after 12 hrs by UV-spectrophotometric analysis,Confirmatory,,
256,720516,2,1,,144209934,6049,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
257,720552,2,1,,144209934,6049,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
258,720634,2,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
259,720635,2,1,,144209934,6049,Inconclusive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
260,720636,1,1,,26754509,6049,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
261,720637,2,1,,144209934,6049,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
262,720653,1,1,,26754509,6049,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
263,720659,1,1,,26754509,6049,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
264,720674,2,2,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
265,720675,2,2,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
266,720678,2,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
267,720679,2,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
268,720680,2,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
269,720681,2,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
270,720682,2,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
271,720683,2,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
272,720684,2,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
273,720685,2,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
274,720686,2,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
275,720687,2,2,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
276,720691,4,1,,144209934,6049,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
277,720692,3,1,,144209934,6049,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
278,720693,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
279,720719,2,1,,144209934,6049,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
280,720725,2,1,,144209934,6049,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
281,743012,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
282,743014,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
283,743015,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
284,743033,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
285,743035,2,1,,144209934,6049,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
286,743036,2,1,,144209934,6049,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
287,743040,3,1,,144209934,6049,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
288,743041,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
289,743042,3,1,,144209934,6049,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
290,743053,2,1,,144209934,6049,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
291,743054,2,1,,144209934,6049,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
292,743063,2,1,,144209934,6049,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
293,743064,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
294,743065,3,1,,144209934,6049,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
295,743066,3,1,,144209934,6049,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
296,743067,2,1,,144209934,6049,Inconclusive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
297,743069,2,1,,144209934,6049,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
298,743074,2,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
299,743075,2,1,,144209934,6049,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
300,743077,2,1,,144209934,6049,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
301,743078,2,1,,144209934,6049,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
302,743079,3,1,,144209934,6049,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
303,743080,3,1,,144209934,6049,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
304,743081,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
305,743083,3,1,,144209934,6049,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
306,743084,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
307,743085,3,1,,144209934,6049,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
308,743086,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
309,743091,2,1,,144209934,6049,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
310,743094,3,1,,144209934,6049,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
311,743122,2,1,,144209934,6049,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
312,743139,2,1,,144209934,6049,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
313,743140,2,1,,144209934,6049,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
314,743191,3,1,,144209934,6049,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
315,743194,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
316,743199,2,1,,144209934,6049,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
317,743202,4,1,,144209934,6049,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
318,743203,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
319,743209,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
320,743210,4,1,,144209934,6049,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
321,743211,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
322,743212,3,1,,144209934,6049,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
323,743213,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
324,743215,3,1,,144209934,6049,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
325,743217,3,1,,144209934,6049,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
326,743218,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
327,743219,3,1,,144209934,6049,Inactive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
328,743220,3,1,,144209934,6049,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
329,743221,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
330,743222,3,1,,144209934,6049,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
331,743223,3,1,,144209934,6049,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
332,743224,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
333,743225,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
334,743226,2,1,,144209934,6049,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
335,743227,2,1,,144209934,6049,Inconclusive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
336,743228,3,1,,144209934,6049,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
337,743239,2,1,,144209934,6049,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
338,743240,2,1,,144209934,6049,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
339,743241,2,1,,144209934,6049,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
340,743242,2,1,,144209934,6049,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
341,743288,1,1,,26754509,6049,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
342,743292,1,1,,26754509,6049,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
343,751210,1,1,,103224342,6049,Unspecified,,,54.0,IC50,Antioxidant activity assessed as inhibiton of Fe2+-induced Fenton reaction-mediated hydroxyl radical formation from H2O2 measured for 150 secs by ESR analysis in presence of DMPO,Confirmatory,23751098.0,
344,767774,1,1,,103224342,6049,Active,,,0.1,IC50,Inhibition of NDM-1 (unknown origin) expressed in Escherichia coli BL21 using meropenem as substrate compound preincubated for 15 min by spectrophotometry,Confirmatory,23972215.0,
345,769911,1,1,,103224342,6049,Active,,,28.4,IC50,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,Confirmatory,23905680.0,
346,769915,1,1,,103224342,6049,Active,,,7.7,IC50,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,Confirmatory,23905680.0,
347,977599,1,1,,103224342,6049,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
348,977602,1,2,,103224342,6049,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
349,1060585,1,2,,103224342,6049,Unspecified,112927.0,351.0,,,Inhibition of Cu2+-induced amyloid beta (1 to 42) (unknown origin) aggregation assessed as reduction of H2O2 production at 800 nM after 30 mins by HRP/Amplex red assay,Other,24269515.0,
350,1085844,2,2,,103224342,6049,Unspecified,,,74.0,IC50,Inhibition of Serpentes (snake) venom phosphodiesterase using bis(p-nitrophenyl)phosphate as substrate incubated for 30 min prior to substrate addition by spectrophotometric analysis,Confirmatory,,
351,1087331,3,1,,103224342,6049,Unspecified,,,,,Antioxidant activity assessed as Fe2+ chelating activity after 10 min by spectrophotometry,Other,,
352,1116458,1,2,,103224342,6049,Unspecified,,,,,Antioxidant activity assessed as Fe2+ chelating activity at 0.037 mg/ml after 90 min by spectrophotometric analysis,Other,,
353,1116936,1,3,,103224342,6049,Unspecified,,,274.0,IC50,Inhibition of snake venom phosphodiesterase using bis-(para-nitrophenyl)phosphate as substrate after 30 min by spectrophotometric analysis,Confirmatory,,
354,1159509,1,1,,144209934,6049,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
355,1159515,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
356,1159516,1,1,,144209934,6049,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
357,1159517,1,1,,144209934,6049,Inconclusive,,,0.2195,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
358,1159518,1,1,,144209934,6049,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
359,1159519,1,1,,144209934,6049,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
360,1159520,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
361,1159521,1,1,,144209934,6049,Inconclusive,15928672.0,19885.0,2.1761,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
362,1159523,1,1,,144209934,6049,Inconclusive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
363,1159525,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
364,1159526,1,1,,144209934,6049,Inconclusive,119627033.0,3725.0,2.7634,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
365,1159527,1,1,,144209934,6049,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
366,1159528,1,1,,144209934,6049,Inconclusive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
367,1159529,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
368,1159531,1,1,,144209934,6049,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
369,1159551,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
370,1159552,1,1,,144209934,6049,Inactive,325495463.0,5914.0,1.9394,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
371,1159553,2,1,,144209934,6049,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
372,1159555,1,1,,144209934,6049,Inconclusive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
373,1159580,2,1,,268734536,6049,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
374,1159607,2,1,,312996238,6049,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
375,1169669,1,2,,103224342,6049,Unspecified,1168998.0,4322.0,,,Inhibition of full-length recombinant human MMP-13 assessed as prevention of bovine type-2 collagen degradation at 50 uM after 18 hrs by cartilage explant assay,Other,25330343.0,
376,1172496,1,1,,103224342,6049,Unspecified,,,277.69,IC50,Inhibition of snake venom NPP1 using bis(p-nitrophenyl)phosphate preincubated for 30 mins by spectrophotometry,Confirmatory,25440732.0,
377,1173791,1,1,,103224342,6049,Unspecified,,,,,Metal chelating activity of the compound assessed as formation of iron complex after 20 mins by spectrophotometry,Other,25456077.0,
378,1224834,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
379,1224835,1,1,,144209934,6049,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
380,1224836,1,1,,144209934,6049,Inconclusive,,,3.4489,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
381,1224837,1,1,,144209934,6049,Inconclusive,,,2.4416,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
382,1224838,1,1,,144209934,6049,Active,66775687.0,9970.0,1.9394,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
383,1224839,1,1,,144209934,6049,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
384,1224840,3,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
385,1224841,3,1,,144209934,6049,Active,325495545.0,2101.0,0.1939,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
386,1224842,3,1,,144209934,6049,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
387,1224843,1,1,,144209934,6049,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
388,1224844,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
389,1224845,1,1,,144209934,6049,Active,344243002.0,100757539.0,4.5152,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
390,1224846,1,1,,144209934,6049,Inconclusive,11995455.0,3091.0,3.1006,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
391,1224847,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
392,1224848,3,1,,144209934,6049,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
393,1224849,3,1,,144209934,6049,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
394,1224863,1,1,,316919528,6049,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
395,1224867,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
396,1224868,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
397,1224869,1,1,,144209934,6049,Active,,,1.9563,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
398,1224870,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
399,1224871,1,1,,144209934,6049,Inconclusive,,,1.9563,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
400,1224872,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
401,1224873,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
402,1224874,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
403,1224875,1,1,,144209934,6049,Inconclusive,,,1.9563,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
404,1224876,1,1,,144209934,6049,Active,,,1.7436,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
405,1224877,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
406,1224878,1,1,,144209934,6049,Active,,,1.7436,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
407,1224879,1,1,,144209934,6049,Active,,,1.9563,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
408,1224880,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
409,1224881,1,1,,144209934,6049,Inconclusive,,,1.9563,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
410,1224882,1,1,,144209934,6049,Active,,,1.7436,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
411,1224883,1,1,,144209934,6049,Active,,,1.7436,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
412,1224884,1,1,,144209934,6049,Active,,,1.9563,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
413,1224885,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
414,1224886,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
415,1224887,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
416,1224888,1,1,,144209934,6049,Active,,,1.9563,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
417,1224889,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
418,1224890,1,1,,144209934,6049,Active,,,1.7436,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
419,1224892,1,1,,144209934,6049,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
420,1224893,1,1,,144209934,6049,Inconclusive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
421,1224894,1,1,,144209934,6049,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
422,1224895,1,1,,144209934,6049,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
423,1224896,1,1,,144209934,6049,Inconclusive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
424,1245381,1,1,,103224342,6049,Unspecified,,,,,Metal chelating activity of the compound assessed as reduction of Cu2+-amyloid beta (1 to 42)-complex induced H2O2 production from ascorbate at 800 nM after 30 mins by HRP/Amplex Red assay relative to control,Other,26337018.0,
425,1256112,1,1,,103224342,6049,Unspecified,,,54.0,IC50,Antioxidant activity assessed as inhibition of Fe2+-induced DMPO-OH adduct formation from H2O2 preincubated for 30 secs followed by DMPO/H2O2 addition measured after 150 secs by ESR analysis,Confirmatory,26447940.0,
426,1259241,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
427,1259242,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
428,1259243,1,1,,144209934,6049,Inactive,124375976.0,367.0,1.0906,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
429,1259244,1,1,,144209934,6049,Inconclusive,348019627.0,2099.0,3.8697,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
430,1259247,1,1,,144209934,6049,Inconclusive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
431,1259248,1,1,,144209934,6049,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
432,1259310,1,1,,321947241,6049,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
433,1259364,1,1,,144209934,6049,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
434,1259365,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
435,1259366,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
436,1259367,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
437,1259368,1,1,,144209934,6049,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
438,1259369,1,1,,144209934,6049,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
439,1259377,1,1,,144209934,6049,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
440,1259378,1,1,,144209934,6049,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
441,1259379,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
442,1259380,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
443,1259381,1,1,,144209934,6049,Active,124375976.0,367.0,0.7721,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
444,1259382,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
445,1259383,1,1,,144209934,6049,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
446,1259384,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
447,1259385,1,1,,144209934,6049,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
448,1259386,1,1,,144209934,6049,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
449,1259387,1,1,,144209934,6049,Inconclusive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
450,1259388,1,1,,144209934,6049,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
451,1259390,1,1,,144209934,6049,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
452,1259391,1,1,,144209934,6049,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
453,1259392,1,1,,144209934,6049,Inconclusive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
454,1259393,1,1,,144209934,6049,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
455,1259394,1,1,,144209934,6049,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
456,1259395,1,1,,144209934,6049,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
457,1259396,1,1,,144209934,6049,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
458,1259401,1,1,,144209934,6049,Inconclusive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
459,1259402,1,1,,144209934,6049,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
460,1259403,1,1,,144209934,6049,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
461,1259404,1,1,,144209934,6049,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
462,1259407,1,1,,363898896,6049,Inactive,,,,,CCRIS mutagenicity studies,Other,,
463,1259408,1,1,,363894895,6049,Active,,,,,GENE-TOX mutagenicity studies,Other,,
464,1259416,1,2,,340082253,6049,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
465,1259421,1,1,,340082253,6049,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
466,1259423,1,2,,354933283,6049,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
467,1259423,1,2,,354940467,6049,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
468,1259423,1,2,,354941686,6049,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
